218 related articles for article (PubMed ID: 1465145)
1. Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer.
Wolfe JH; Sands MS; Barker JE; Gwynn B; Rowe LB; Vogler CA; Birkenmeier EH
Nature; 1992 Dec 24-31; 360(6406):749-53. PubMed ID: 1465145
[TBL] [Abstract][Full Text] [Related]
2. Delivery of a retroviral vector expressing human beta-glucuronidase to the liver and spleen decreases lysosomal storage in mucopolysaccharidosis VII mice.
Gao C; Sands MS; Haskins ME; Ponder KP
Mol Ther; 2000 Sep; 2(3):233-44. PubMed ID: 10985954
[TBL] [Abstract][Full Text] [Related]
3. Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts.
Moullier P; Bohl D; Heard JM; Danos O
Nat Genet; 1993 Jun; 4(2):154-9. PubMed ID: 8348154
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer of low levels of beta-glucuronidase corrects hepatic lysosomal storage in a large animal model of mucopolysaccharidosis VII.
Wolfe JH; Sands MS; Harel N; Weil MA; Parente MK; Polesky AC; Reilly JJ; Hasson C; Weimelt S; Haskins ME
Mol Ther; 2000 Dec; 2(6):552-61. PubMed ID: 11124056
[TBL] [Abstract][Full Text] [Related]
5. Brain transplantation of genetically modified bone marrow stromal cells corrects CNS pathology and cognitive function in MPS VII mice.
Sakurai K; Iizuka S; Shen JS; Meng XL; Mori T; Umezawa A; Ohashi T; Eto Y
Gene Ther; 2004 Oct; 11(19):1475-81. PubMed ID: 15295619
[TBL] [Abstract][Full Text] [Related]
6. Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice.
Skorupa AF; Fisher KJ; Wilson JM; Parente MK; Wolfe JH
Exp Neurol; 1999 Nov; 160(1):17-27. PubMed ID: 10630187
[TBL] [Abstract][Full Text] [Related]
7. Cross-correction of beta-glucuronidase deficiency by retroviral vector-mediated gene transfer.
Taylor RM; Wolfe JH
Exp Cell Res; 1994 Oct; 214(2):606-13. PubMed ID: 7925654
[TBL] [Abstract][Full Text] [Related]
8. Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery.
Richard M; Arfi A; Seguin J; Gandolphe C; Scherman D
Gene Ther; 2009 Jun; 16(6):746-56. PubMed ID: 19357715
[TBL] [Abstract][Full Text] [Related]
9. Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse.
Meng XL; Shen JS; Ohashi T; Maeda H; Kim SU; Eto Y
J Neurosci Res; 2003 Oct; 74(2):266-77. PubMed ID: 14515356
[TBL] [Abstract][Full Text] [Related]
10. Genetic correction of the fetal brain increases the lifespan of mice with the severe multisystemic disease mucopolysaccharidosis type VII.
Karolewski BA; Wolfe JH
Mol Ther; 2006 Jul; 14(1):14-24. PubMed ID: 16624622
[TBL] [Abstract][Full Text] [Related]
11. High level expression and export of beta-glucuronidase from murine mucopolysaccharidosis VII cells corrected by a double-copy retrovirus vector.
Wolfe JH; Kyle JW; Sands MS; Sly WS; Markowitz DG; Parente MK
Gene Ther; 1995 Jan; 2(1):70-8. PubMed ID: 7712336
[TBL] [Abstract][Full Text] [Related]
12. In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors.
Stein CS; Kang Y; Sauter SL; Townsend K; Staber P; Derksen TA; Martins I; Qian J; Davidson BL; McCray PB
Mol Ther; 2001 Jun; 3(6):850-6. PubMed ID: 11407898
[TBL] [Abstract][Full Text] [Related]
13. Systemic hyperosmolality improves beta-glucuronidase distribution and pathology in murine MPS VII brain following intraventricular gene transfer.
Ghodsi A; Stein C; Derksen T; Martins I; Anderson RD; Davidson BL
Exp Neurol; 1999 Nov; 160(1):109-16. PubMed ID: 10630195
[TBL] [Abstract][Full Text] [Related]
14. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates.
Sands MS; Barker JE; Vogler C; Levy B; Gwynn B; Galvin N; Sly WS; Birkenmeier E
Lab Invest; 1993 Jun; 68(6):676-86. PubMed ID: 8515654
[TBL] [Abstract][Full Text] [Related]
15. Engraftment of genetically engineered amniotic epithelial cells corrects lysosomal storage in multiple areas of the brain in mucopolysaccharidosis type VII mice.
Kosuga M; Sasaki K; Tanabe A; Li XK; Okawa H; Ogino I; Okuda O; Arai H; Sakuragawa N; Kamata Y; Azuma N; Suzuki S; Yamada M; Okuyama T
Mol Ther; 2001 Feb; 3(2):139-48. PubMed ID: 11237670
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for lysosomal disorders.
Naffakh N; Bohl D; Salvetti A; Moullier P; Danos O; Heard JM
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S11-6. PubMed ID: 8177709
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of abnormal amounts of glycosaminoglycans in murine mucopolysaccharidosis type VII neural progenitor cells does not alter the growth rate or efficiency of differentiation into neurons.
Heuer GG; Skorupa AF; Prasad Alur RK; Jiang K; Wolfe JH
Mol Cell Neurosci; 2001 Jan; 17(1):167-78. PubMed ID: 11161477
[TBL] [Abstract][Full Text] [Related]
18. Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII.
Frisella WA; O'Connor LH; Vogler CA; Roberts M; Walkley S; Levy B; Daly TM; Sands MS
Mol Ther; 2001 Mar; 3(3):351-8. PubMed ID: 11273777
[TBL] [Abstract][Full Text] [Related]
19. Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors.
Bosch A; Perret E; Desmaris N; Heard JM
Mol Ther; 2000 Jan; 1(1):63-70. PubMed ID: 10933913
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation has a significant effect on enzyme levels and storage of glycosaminoglycans in tissues and in isolated hepatocytes of mucopolysaccharidosis type VII mice.
Poorthuis BJ; Romme AE; Willemsen R; Wagemaker G
Pediatr Res; 1994 Aug; 36(2):187-93. PubMed ID: 7970933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
